Use of Cytosponge as a triaging tool to upper gastrointestinal endoscopy during the COVID-19 pandemic.
Pilonis, Nastazja D
The Lancet Gastroenterology and Hepatology
MetadataShow full item record
Di Pietro, M., Modolell, I., O'Donovan, M., Price, C., Pilonis, N. D., Debiram-Beecham, I., & Fitzgerald, R. (2020). Use of Cytosponge as a triaging tool to upper gastrointestinal endoscopy during the COVID-19 pandemic.. The Lancet Gastroenterology and Hepatology, 5 (9), 805-806. https://doi.org/10.1016/S2468-1253(20)30242-9
During the COVID-19 pandemic, endoscopy services have been severely curtailed—eg, in England, UK, a 30% reduction of diagnostic endoscopies has been reported for the period between January and April, 2020, compared with the same period in 2019, with an estimated 750 oesophagogastric cancers going undiagnosed. A delay in oesophageal cancer diagnosis could adversely affect outcomes, such as has previously been seen with low endoscopy referral rates being linked with poor outcomes from oesophageal cancer.
External DOI: https://doi.org/10.1016/S2468-1253(20)30242-9
This record's URL: https://www.repository.cam.ac.uk/handle/1810/310111
All rights reserved